Immunologic and Virologic Outcomes of Obese and Nonobese Incarcerated Adults on Antiretroviral Therapy for HIV Infection

J Int Assoc Provid AIDS Care. 2018 Jan-Dec:17:2325957417752261. doi: 10.1177/2325957417752261.

Abstract

Background: Obesity is common among patients with HIV. The objective of this study was to characterize response to antiretroviral therapy (ART) in a cohort of obese incarcerated adults compared to a nonobese cohort.

Methods: A retrospective matched cohort study was conducted in an HIV telemedicine clinic. Patients with body mass index (BMI) >30 kg/m2 who received the same ART with >95% adherence for at least 6 months were matched to nonobese patients by age, gender, ART, CD4 count, and viral load at baseline.

Results: Twenty pairs were included, with an average BMI of 24 kg/m2 in the nonobese cohort and 35 kg/m2 in the obese cohort. No difference was observed in the proportion of patients who achieved virologic suppression or the change in CD4 count from baseline to 6 to 12 months.

Conclusion: This study revealed no differences in immunologic recovery or virologic suppression between obese and nonobese patients in an adult correctional population.

Keywords: HIV infection; antiretroviral therapy; obesity.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Anti-HIV Agents / therapeutic use*
  • Body Mass Index
  • CD4 Lymphocyte Count
  • Female
  • HIV Infections / drug therapy*
  • HIV Infections / immunology*
  • HIV-1 / immunology
  • Humans
  • Male
  • Middle Aged
  • Obesity / immunology*
  • Obesity / virology*
  • Prisoners*
  • Retrospective Studies
  • Viral Load / drug effects

Substances

  • Anti-HIV Agents